Artelo BiosciencesARTL
13F holders, Q2 2026 (June 30)10holders
5new positions
4sold out
$1.13avg. 13F price*
At the end of Q2 2026, 10 institutions reported holding Artelo Biosciences Inc. (ARTL) in their 13F filings, unchanged from Q1 2026. 5 opened new positions and 4 sold out. The largest holders were Jane Street Group, LLC ($74K), Geode Capital Management, LLC ($16K) and StoneX Group Inc. ($15K).
- Company
- Artelo Biosciences Inc.
- CUSIP
- 04301G706
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $33K |
| Exits | 4 | $125K |
All 13F filers, Q1 2026 → Q2 2026: 87,942 shares bought and 16,427 shares sold, net +71,515 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Jane Street Group, LLC | 0.00% | Add +407.2% | 66,341 | $74K |
| Geode Capital Management, LLC | 0.00% | New | 13,864 | $16K |
| StoneX Group Inc. | 0.00% | New | 12,400 | $15K |
| Vanguard Capital Management LLC | 0.00% | No change | 10,129 | $11K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +198.5% | 8,435 | $9K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 3,139 | $4K |
| UBS Group AG | 0.00% | New | 2,804 | $3K |
| Rothschild Investment LLC | 0.00% | No change | 2 | $2 |
| TD Waterhouse Canada Inc. | 0.00% | New | 2 | $2 |
| Danske Bank A/S | 0.00% | New | 1 | $1 |
"% of holder's portfolio" is ARTL's weight in each manager's 13F, not the share of Artelo Biosciences Inc. the manager owns.